Moderna's mRNA flu vaccine is more effective than the standard shot in a late-stage trial

Moderna’s mRNA flu vaccine gave more protection against illness than the standard flu shot in a phase 3 clinical trial, according to published results.
WAMC

FDA reverses course on Moderna flu shot

The Food and Drug Administration rattled the biotech industry last week when it said it wouldn't even look at Moderna's application to market the first mRNA flu shot. But on Wednesday, the agency ...

Moderna reports strong 5-year cancer vaccine data, expands CEPI partnership; stock falls

Moderna, Inc. MRNA stock is trading lower on Monday. The COVID-19 vaccine maker and Merck & Co Inc. MRK reported five-year ...

Moderna secures millions for Ebola vaccine as it searches for life after Covid

Moderna secures up to $50 million to develop an Ebola vaccine.
wtvr

Moderna says it's developing a COVID-19 vaccine booster that doubles as a flu shot

Moderna says it is in the process of developing a single-shot vaccine that could serve as a COVID-19 booster shot and a flu shot. In a press release Thursday touting its fifth annual "R&D Day," ...